Medicine
Vancomycin 750 mg/150 mL injection
Vancomycin 750 mg/150 mL injection is a generic prescription medicine for intravenous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store below 25°C (77ºF), in original package.
Key facts
- Active ingredient (INN)
- Vancomycin
- Brand
- Sold under the generic name
- Strength
- 750 mg/150 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 150 mL, 6 bags of 150 mL, 12 bags of 150 mL
- Manufacturers
- Xellia PharmaceuticalsBaxter Healthcare
- Origin register
- US FDA, United States
- Storage
- Store below 25°C (77ºF), in original package.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07AA09 Vancomycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 November 1958
- Identifiers
- RxCUI 1807508, 1807510, 1807511 +4DailyMed set ID 60bee69b-be70-412c-9e83-a24a0a8a5e7b, 99e523d8-9bde-43cb-8434-497015e5dcbdNDC 70594-056, 0338-3582Application NDA211962, NDA050671
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 150 mL in 1 bag | 0338-3582-01 | Baxter Healthcare | 18 December 2015 |
| 6 bag in 1 carton / 150 mL in 1 bag | 70594-056-02 | Xellia Pharmaceuticals | 13 May 2020 |
| 12 bag in 1 carton / 150 mL in 1 bag | 70594-056-03 | Xellia Pharmaceuticals | 13 May 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 April 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Vancomycin 750 mg/150 mL injection.
Other strengths and forms of Vancomycin
Clinical summary
Vancomycin is a glycopeptide antibacterial indicated for the treatment of Clostridioides difficile -associated diarrhea, among other approved uses. It is available as powder for injection, injection and capsules for intravenous, oral and intravitreal use. MedsAcross supplies Vancomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VancomycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- vancomycin hydrochloride prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Vancomycin 750 mg/150 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.